Complications and management of ventriculoatrial (VA) shunts, a case report
2010

Complications and Management of VA Shunts: A Case Report

publication Evidence: low

Author Information

Author(s): Nash David L, Schmidt Kevin

Primary Institution: Mayo Clinic

Hypothesis

Should all patients with VA shunts be anticoagulated, to what extent?

Conclusion

Clinically evident and subclinical thromboembolic disease is a known complication of VA shunts, and management is largely undefined.

Supporting Evidence

  • The rate of clinically evident pulmonary embolism in patients with VA shunts is only 0.4%.
  • Autopsy studies have shown rates of pulmonary embolism as high as 59.7%.
  • Long-term anticoagulation is a difficult recommendation to generalize to an asymptomatic population.

Takeaway

This study looks at problems that can happen with a type of medical device called a VA shunt and how to take care of those problems.

Methodology

A literature review of VA shunt complications and long-term management was performed, with consultations from various medical specialties.

Limitations

There is a lack of literature regarding the complications and long-term management of VA shunts.

Participant Demographics

An 18-year-old female with a history of myelomeningocele and hydrocephalus.

Digital Object Identifier (DOI)

10.1186/1743-8454-7-S1-S42

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication